Advanced Therapeutic Antibody Discovery with Multiplexed Screening
White Paper Nov 25, 2018
Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating numerous diseases including cancer, autoimmune disorders and infectious disease.
Multiplexed high throughput screening has become an essential component in the discovery of therapeutic antibodies.
Download this whitepaper to learn:
• How to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens.
• How the Intellicyt® iQue Screener PLUS platform can be used to carry out high content assays to evaluate the effects of lead candidates in multiplexed cell based and secreted protein assays.
Related White Papers
Neutralizing antibodies are currently being investigated as one such strategy against SARS-CoV-2, as they have the potential to block the virus from infecting host cells. Download this whitepaper to learn more about the antiviral mechanism of SARS-CoV-2 neutralizing antibodies and global efforts to develop neutralizing antibody products against the virus.READ MORE
Like what you just read? You can find similar content on the communities below.Analysis & Separations Cancer Research Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE